日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

pH-Responsive Polyethylene Glycol Engagers for Enhanced Brain Delivery of PEGylated Nanomedicine to Treat Glioblastoma

用于增强聚乙二醇化纳米药物脑递送以治疗胶质母细胞瘤的pH响应型聚乙二醇载体

期刊:ACS Nano
影响因子:16
doi:10.1021/acsnano.4c05906
Meng, Jun-Lun; Dong, Zi-Xuan; Chen, Yan-Ru; Lin, Meng-Hsuan; Liu, Yu-Ching; Roffler, Steve R; Lin, Wen-Wei; Chang, Chin-Yuan; Tzou, Shey-Cherng; Cheng, Tian-Lu; Huang, Hsiao-Chen; Li, Zhi-Qin; Lin, Yen-Cheng; Su, Yu-Cheng
细胞生物学
神经科学
发表日期：2025
文献求助 收藏

To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization

为了生成功能性抗蛋白酶激活受体4 (PAR4)（一种G蛋白偶联受体）抗体，可通过PAR4-mRNA-LNP免疫接种实现。

期刊:NPJ Vaccines
影响因子:6.5
doi:10.1038/s41541-025-01283-x
Liu, En-Shuo; Ho, Kai-Wen; Wu, Chin-Chung; Fan, Hsiao-Li; Wang, Ting-Yu; Hsieh, Yuan-Chin; Huang, Bo-Cheng; Hong, Shih-Ting; Liao, Tzu-Yi; Liu, Yen-Ling; Chen, Yu-Tung; Lee, Chia-Ching; Chen, Chiao-Yun; Lin, Chih-Lung; Cheng, Tian-Lu
PAR4
信号转导
免疫/内分泌
发表日期：2025
文献求助 收藏

Spatial-hindrance-based pro-Adalimumab prevents anti-idiotypic antibody interference in pharmacokinetic and therapeutic efficacy.

基于空间阻碍的pro-Adalimumab可防止抗独特型抗体干扰药代动力学和治疗效果

期刊:Bioengineering & Translational Medicine
影响因子:5.7
doi:10.1002/btm2.70015
Huang Bo-Cheng, Chen Yu-Tung, Lu Yun-Chi, Ho Kai-Wen, Hong Shih-Ting, Liao Tzu-Yi, Wu I-Hsuan, Liu En-Shuo, Liao Jun-Min, Chen Fang-Ming, Li Chia-Ching, Chuang Chih-Hung, Chen Chiao-Yun, Cheng Tian-Lu
免疫/内分泌
发表日期：2025
文献求助 收藏

Strategies for Non-Covalent Attachment of Antibodies to PEGylated Nanoparticles for Targeted Drug Delivery

用于靶向药物递送的抗体与聚乙二醇化纳米颗粒的非共价连接策略

期刊:International Journal of Nanomedicine
影响因子:6.5
doi:10.2147/IJN.S479270
Ho, Kai-Wen; Liu, Yen-Ling; Liao, Tzu-Yi; Liu, En-Shuo; Cheng, Tian-Lu
发表日期：2024
文献求助 收藏

A non-genetic engineering platform for rapidly generating and expanding cancer-specific armed T cells

一种用于快速生成和扩增癌症特异性武装T细胞的非基因工程平台

期刊:Journal of Biomedical Science
影响因子:12.1
doi:10.1186/s12929-023-00929-z
Chen, Yi-Jou; Chen, Michael; Cheng, Tian-Lu; Tsai, Yi-Shan; Wang, Chang-Hung; Chen, Che-Yi; Wu, Tung-Yun; Tzou, Shey-Cherng; Wang, Kai-Hung; Cheng, Jing-Jy; Kao, An-Pei; Lin, Shyr-Yi; Chuang, Kuo-Hsiang
肿瘤
T细胞
肿瘤免疫
T细胞
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies.

一种用于开发人源化单克隆抗体的通用计算机模拟V(D)J重组策略

期刊:Journal of Nanobiotechnology
影响因子:12.6
doi:10.1186/s12951-022-01259-2
Hsieh Yuan-Chin, Liao Jun-Min, Chuang Kuo-Hsiang, Ho Kai-Wen, Hong Shih-Ting, Liu Hui-Ju, Huang Bo-Cheng, Chen I-Ju, Liu Yen-Ling, Wang Jaw-Yuan, Tsai Hsiang-Lin, Su Yu-Cheng, Wang Yen-Tseng, Cheng Tian-Lu
其它
Human
发表日期：2022
文献求助 收藏

Fibrinogen-Like Protein 1 Serves as an Anti-Inflammatory Agent for Collagen-Induced Arthritis Therapy in Mice.

纤维蛋白原样蛋白 1 可作为抗炎剂用于治疗小鼠胶原蛋白诱导的关节炎

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2021.767868
Lin Wen-Wei, Ho Kai-Wen, Su Hsiang-Han, Fang Tien-Fang, Tzou Shey-Cherng, Chen I-Ju, Lu Yun-Chi, Chang Mu-Shen, Tsai Yun-Chen, Liu En-Shuo, Su Yu-Cheng, Wang Yen-Tseng, Cheng Tian-Lu, Huang Hsin-Kai
炎症/感染
关节炎
炎症
发表日期：2021
文献求助 收藏

A Pilot Study of Silymarin as Supplementation to Reduce Toxicities in Metastatic Colorectal Cancer Patients Treated With First-Line FOLFIRI Plus Bevacizumab

水飞蓟素作为补充剂降低一线 FOLFIRI 联合贝伐单抗治疗转移性结直肠癌患者毒性的初步研究

期刊:Oncology Research
影响因子:4.1
doi:10.3727/096504021X16218531628569
Chang, Tsung-Kun; Yin, Tzu-Chieh; Su, Wei-Chih; Tsai, Hsiang-Lin; Huang, Ching-Wen; Chen, Yen-Cheng; Li, Ching-Chun; Chen, Po-Jung; Ma, Cheng-Jen; Chuang, Kuo-Hsiang; Cheng, Tian-Lu; Wang, Jaw-Yuan
毒理研究
肿瘤
肠癌
肿瘤免疫
发表日期：2021
文献求助 收藏

Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy.

选择性激活促抗IL-1β抗体可增强自身炎症性疾病治疗的特异性

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-021-94298-y
Lin Wen-Wei, Lu Yun-Chi, Huang Bo-Cheng, Chuang Chih-Hung, Cheng Yi-An, Chen I-Ju, Liu Hui-Ju, Ho Kai-Wen, Liao Tzu-Yi, Liu En-Shuo, Wu Ting-Yi, Chang Long-Sen, Hong Shih-Ting, Cheng Tian-Lu
免疫/内分泌
炎症
发表日期：2021
文献求助 收藏

Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer

人源化双特异性抗体（mPEG × HER2）可快速赋予聚乙二醇化纳米颗粒肿瘤特异性，用于乳腺癌的多模态成像

期刊:Journal of Nanobiotechnology
影响因子:12.6
doi:10.1186/s12951-020-00680-9
Cheng, Yi-An; Wu, Tung-Ho; Wang, Yun-Ming; Cheng, Tian-Lu; Chen, I-Ju; Lu, Yun-Chi; Chuang, Kuo-Hsiang; Wang, Chih-Kuang; Chen, Chiao-Yun; Lin, Rui-An; Chen, Huei-Jen; Liao, Tzu-Yi; Liu, En-Shuo; Chen, Fang-Ming
肿瘤
HER2
肿瘤免疫
乳腺癌
Human
发表日期：2020
文献求助 收藏